Total Revenue: Increased by 33% year over year to $28.1 million. Adjusted EBITDA: Grew by 54% year over year to $16.7 million. Adjusted Net Income: Increased by 65% year over year to $14.9 million or ...
International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, ...
Abacus Global Management Inc (NASDAQ:ABL) reported a significant increase in total revenue, nearly doubling year-over-year to $56.2 million. The company achieved a strong adjusted net income of $21.9 ...
Insights from the Secured Finance Network show steady ABL activity and strong factoring growth despite a moderating economic environment and a flurry of private credit headlines The Secured Finance ...
WOIPPY, MOSELLE, FRANCE, March 11, 2026 /EINPresswire.com/ — ABL Diagnostics (FR001400AHX6 – “ABLD”) announces strengthened positioning in HIV‑1 genomics ...
ABL Space System’s RS1 rocket undergoing acceptance testing. The company signed a contract with Lockheed Martin for as many as 58 RS1 launches through 2029. Credit: ABL Space Systems WASHINGTON — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results